{"id":"NCT00799903","sponsor":"GlaxoSmithKline","briefTitle":"The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial","officialTitle":"LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12-01","primaryCompletion":"2013-10-01","completion":"2013-10-17","firstPosted":"2008-12-01","resultsPosted":"2017-08-10","lastUpdate":"2017-08-10"},"enrollment":15828,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Atherosclerosis"],"interventions":[{"type":"DRUG","name":"Darapladib","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Darapladib","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or stroke) in people with coronary heart disease.","primaryOutcome":{"measure":"Number of Participants With First Occurrence of Any Component of the Composite of Major Adverse Cardiovascular Events (Cardiovascular [CV] Death, Non-fatal Myocardial Infarction [MI] or Non-fatal Stroke) During the Time Period for Follow-up of CV Events","timeFrame":"From randomization until the End-of-Treatment visit or the last date on which endpoints were able to be assessed (up to 4.25 years/average of 3.51 years)","effectByArm":[{"arm":"Placebo","deltaMin":819,"sd":null},{"arm":"Darapladib","deltaMin":769,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.199"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":13},"locations":{"siteCount":650,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Canada","Chile","China","Czechia","Denmark","Estonia","France","Germany","Greece","Hong Kong","Hungary","India","Italy","Japan","Mexico","Netherlands","New Zealand","Norway","Pakistan","Peru","Philippines","Poland","Romania","Russia","Slovakia","South Africa","South Korea","Spain","Sweden","Taiwan","Thailand","Ukraine","United Kingdom"]},"refs":{"pmids":["39390990","35861814","35060389","34562103","33439866","32480059","32375553","30897999","29066452","28960596","28912210","28862971","28797349","28735759","27811204","27329448","26920728","26672609","24721691","24678955","22496275"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":3448,"n":7890},"commonTop":["Diarrhoea","Hypertension","Type 2 diabetes mellitus","Nasopharyngitis","Angina pectoris"]}}